Continental Advisors’s CONMED CNMD Stock Holding History

Continental Advisors’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-18,000	Closed	-$799K	–	131
2017 Q1	$799K	Hold	18,000	–	–	0.18%	106
2016 Q4	$795K	Sell	18,000 -13,400	-43%	-$569K	0.22%	102
2016 Q3	$1.26M	Buy	31,400 +5,000	+19%	+$212K	0.35%	86
2016 Q2	$1.26M	Hold	26,400	–	–	0.39%	78
2016 Q1	$1.11M	Hold	26,400	–	–	0.31%	85
2015 Q4	$1.16M	Hold	26,400	–	–	0.3%	93
2015 Q3	$1.26M	Hold	26,400	–	–	0.34%	87
2015 Q2	$1.54M	Hold	26,400	–	–	0.41%	80
2015 Q1	$1.33M	Hold	26,400	–	–	0.29%	99
2014 Q4	$1.19M	Hold	26,400	–	–	0.24%	106
2014 Q3	$973K	Buy	+26,400	New	+$1.05M	0.22%	106

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

CRM

Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Continental Advisors's CNMD Position: Q2 2017 in Review

Continental Advisors sold out of CONMED (CNMD) in Q2 2017, closing a stake of 18,000 shares — an estimated $799K sold.

Continental Advisors first reported a position in CNMD in Q3 2014 and held it in 11 quarters. The position peaked at $1.54M in Q2 2015. 150 funds tracked by Wall St. Rank hold CNMD as of Q2 2017.

Continental Advisors reported no remaining CONMED position as of Q2 2017 after selling out during the quarter.
Continental Advisors sold 18,000 CONMED shares in Q2 2017, an estimated $799K.
Continental Advisors first reported a position in CONMED in Q3 2014 and held it in 11 quarters.
Continental Advisors's CONMED position peaked at $1.54M in Q2 2015.
150 funds tracked by Wall St. Rank held CONMED as of Q2 2017.

Based on Continental Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.